# BlackRock Technology and Private Equity Term Trust Common Shares of Beneficial Interest (BTX) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Healthcare / Biotechnology. Price $8.94, market value $1.0 billion.

## Valuation
- **P/E (trailing): 2.3×** (5-yr avg 21.1×, 3-yr avg 21.1×). BlackRock Technology and Private Equity Term Trust Common Shares of Beneficial Interest trades at 2.3× trailing earnings, well below its own five-year average of 21.1×: cheap by its own standards. The Healthcare median in the September 2026 study was 28.5×.
- **Price / sales: 90.9×**. Each dollar of revenue is priced at 90.9×, a level that requires very high margins or very fast growth to justify.
- **Price / book: 1.1×**. The shares trade at 1.1× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: 84.1%** (5-yr avg 22.6%). Free cash flow equals 84.1% of the market value, above its five-year average of 22.6%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 43.1%**. The inverse of the P/E: 43.1% of the price is earned each year.

## Profitability
- **Net margin: 75.7%**. 75.7% of each dollar of sales reaches the bottom line.
- **Return on equity: 0.9%**. 0.9% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on assets: 0.9%**. Each dollar of assets produces 0.9% of profit.

## Growth
- **Revenue growth (1 yr): -71.8%**. Revenue fell 71.8% over the last year.
- **Free-cash-flow growth (3 yr): 41.4%/yr**. Free cash flow has compounded at 41.4% a year over three years.

## Dividends
- **Dividend yield: 7.05%** ($0.63 per share, trailing). BlackRock Technology and Private Equity Term Trust Common Shares of Beneficial Interest yields 7.05%, high enough to check carefully: yields this high often precede a cut.
- **Consecutive years of increases: 2**. 2 straight years of increases.
- **Shareholder yield: 76.4%**. Dividends plus net buybacks return 76.4% of the market value a year.

## Price and momentum
- **Total return (1 yr): 39.4%** (YTD 42.6%, 3-mo 3.3%). The shares are up 39.4% over twelve months including dividends.
- **From 52-week high: -5.2%** (45.8% above the low). Trading 5% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 55**. An RSI of 55 is neutral.
- **Beta (1 yr): 1.60** (volatility 29%). Beta of 1.60 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=BTX · Page: https://foliofundamentals.com/stocks/btx

Not investment advice.